早期妊娠三甲胺N-氧化物代谢物与妊娠期糖尿病风险:巢式病例对照研究
基于天津22,302名孕妇的前瞻性队列,开展巢式病例对照研究,纳入243例妊娠期糖尿病(GDM)与243例匹配对照。早期妊娠三甲胺(TMA)与GDM风险呈线性正相关,而TMA前体及TMAO与GDM呈负相关并存在明显阈值效应。高TMAR合并低TMAOR提示TMA蓄积状态,与GDM风险显著升高相关(OR 11.16;95%CI 5.45–22.8)。
要点
- 早期妊娠TMA水平与GDM风险呈线性正相关。
- TMAO、甜菜碱、左卡尼汀及氯化胆碱与GDM呈负相关并存在阈值效应。
- 高TMAR合并低TMAOR提示TMA蓄积,与GDM风险显著升高相关。
核心结论
- 早期妊娠TMAO代谢物与GDM风险相关,其中TMA更可能对GDM发挥因果作用。
研究设计与样本
- 前瞻性队列(2010–2012年天津22,302名孕妇)中开展的巢式病例对照研究。
- 纳入243例GDM孕妇与243例按母亲年龄(±1岁)匹配的非GDM对照。
主要发现
- TMA与GDM呈线性关联,TMA前体及TMAO与GDM呈负相关并存在明显阈值效应。
- TMAO阈值16 nmol/mL,甜菜碱200 nmol/mL,左卡尼汀112 nmol/mL,氯化胆碱110与270 nmol/mL(U型关系)。
- TMAR >0.35且TMAOR ≤0.15者OR为11.16(95%CI 5.45–22.8),仅TMAR >0.35者OR为1.71(95%CI 0.42–6.95),仅TMAOR ≤0.15者OR为2.06(95%CI 1.09–3.90),存在显著相加交互作用。
- 数学交互作用不显著。
关键数值与推荐
- TMAO阈值16 nmol/mL;甜菜碱200 nmol/mL;左卡尼汀112 nmol/mL;氯化胆碱110与270 nmol/mL(U型关系)。
- TMAR定义为TMA/其前体,TMAOR定义为TMAO/TMA。
- 高TMAR合并低TMAOR提示TMA蓄积状态,高TMAR合并高TMAOR提示TMAO蓄积。
临床怎么用
- 早期妊娠可关注TMA及其前体、TMAO代谢谱,辅助评估GDM风险。
- 高TMAR合并低TMAOR提示TMA蓄积状态,与GDM风险显著升高相关,需加强监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This study aimed to investigate the associations between trimethylamine N-oxide (TMAO) and related metabolites in early pregnancy and the risk of gestational diabetes mellitus (GDM). DESIGN: A prospective cohort of 22,302 pregnant women from 2010 to 2012 in Tianjin, China, was used to perform a nested case-control study. A total of 243 women with GDM and 243 women without GDM matched by maternal age (±1 year) were used as cases and controls, respectively. Conditional logistic regression and restricted cubic spline were used to examine the full-range risk associations between individual TMAOs metabolites at the first antenatal care visit with GDM. Trimethylamine conversion ratio (TMAR) was defined as trimethylamine (TMA)/its precursors, and trimethylamine N-oxide conversion ratio (TMAOR) was defined as TMAO/TMA. An additive interaction between high TMAR and low TMAOR indicates a state of TMA accumulation, and a mathematical interaction between high TMAR and high TMAOR indicates accumulation of TMAO. RESULTS: TMA was linearly associated with GDM, whereas TMA precursors and TMAO were inversely associated with GDM with clear threshold effects, i.e., 16 nmol/mL for TMAO, 200 nmol/mL for betaine, 112 nmol/mL for l-carnitine, and 110 and 270 nmol/mL for cholinechloride (a U-shaped relationship). Copresence of TMAR >0.35 and TMAOR ≤0.15 was associated with a markedly higher OR (11.16; 95% CI, 5.45 to 22.8), compared with TMAR >0.35 only (OR = 1.71; 95% CI, 0.42 to 6.95) or TMAOR ≤0.15 only (OR = 2.06; 95% CI, 1.09 to 3.90), with a significant additive interaction. However, the mathematical interaction was nonsignificant. CONCLUSIONS: TMAO metabolites in the early pregnancy were associated with the risk of GDM, whereas TMA was more likely to play a causal role in GDM.
引用
- Huo X, Li J, Cao YF, et al. Trimethylamine N-Oxide Metabolites in Early Pregnancy and Risk of Gestational Diabetes: A Nested Case-Control Study. J Clin Endocrinol Metab. 2019. PMID: 31373635. doi:10.1210/jc.2019-00710
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。